RxDoctor Payments Data

Kristen Crumpton

Nurse Practitioner · Lakeland, FLNPI 1578180493

Payments from drug & device makers

$7,714in general payments, 2019–2025

Across 331 payments — averaging $23.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Pfizer$792
  • Johnson & Johnson$670
  • UCB, Inc.$621
  • Lilly USA, LLC$576
  • Sanofi$493
  • plus $3K from 22 others

What the payments were for

  • Food & beverage$7,55998%
  • Education$1562%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,714 in reported general payments places this provider in the 95th percentile of 8,290 nurse practitioner providers in Florida.

See all nurse practitioner providers in Florida

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab33$134,351
OtezlaApremilast22$99,575
Ammonium Lactate280$8,051
Ciclopirox106$2,573
Clobetasol Propionate63$2,315
Ketoconazole119$1,920
Tacrolimus12$1,737
Fluorouracil15$1,533
Desonide29$945
Hydrocortisone45$839
Tretinoin13$824
Triamcinolone Acetonide70$640
Nystatin40$578
Mometasone Furoate20$560
Doxycycline Hyclate23$428

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenOtezla$160$99,57522 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,290 nurse practitioner providers in Florida.

Other nurse practitioner in Lakeland

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →